Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  oxycodone hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Phase IV Randomized Pilot Study of Oxycodone Hydrochloride Versus Standard Three-Step Analgesic Therapy in Patients With Cancer-Related Pain. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CRUK-ON/2003/1772, EU-20640, EUDRACT-2004-004235-66, NAPP-CRUK-ON/2003/1772, NCT00378937
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
Phase: Phase IV
Type: Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PT-SM-1-Op-Cancer, NCT00916890
Effect of Garlic Supplements on Opioids in Healthy Volunteers
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Completed
Age: 21 to 45
Sponsor: NCI, Other
Protocol IDs: 2040.00, IR-6130, CDR0000551927, FHCRC-2040.00, FHCRC-2040.00p, NCT00499460
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR017188, JNS024ER-KAJ-C02, NCT01165281
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR017437, 42801PAI3009, NCT01205126
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OXN2001, 2007-001313-42, NCT00513656
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A4091003, NCT00545129
Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NEUROPAIN01, EudraCT Number 2007-005222-69, NCT00637975
Start Over